CSHL Genomics Research
Genomics research at CSHL falls into three broad categories, with researchers often crossing between these categories due to the interdisciplinary nature of genomics. The Cognitive Genomics group develops and applies novel technologies to unravel how genetic variation leads to disorders such as autism, schizophrenia, bipolar disorder and major depression. The Cancer Genomics group uses genomics to understand how the cancer genome differs from the normal genome, how these differences lead to the growth and development of cancer and how biomarkers can be used for diagnosis and prognosis. The Plant Genomics group applies genomic approaches to understanding the growth, development and reproduction of plants as a way of improving the access to food and fuel in the future.
CSHL is one of the founding members of the New York Genome Center, an independent, non-profit organization that is leveraging the collaborative resources of 11 leading medical and research institutions to transform medical research and clinical care in New York.